Fluorescent Tools for Imaging and Ligand Screening of Dopamine D<sub>2</sub>-Like Receptors
Abstract The family of dopamine D2-like receptors represent an interesting target for a variety of neurological diseases, e.g. Parkinson’s disease (PD), addiction or schizophrenia. In this study we describe the synthesis of a new set of fluorescent ligands as tools for visualization of dopamine D2-like receptors. Pharmacological characterization in radioligand binding studies identified UR-MN212 (20) as a high-affinity ligand for D2-like receptors (pKi(D2longR) = 8.24, pKi(D3R) = 8.58, pKi(D4R) = 7.78) with decent selectivity towards D1-like receptors. Compound20is a neutral antagonist in a Go1activation assay at the D2longR, D3R and D4R, which is an important feature for studies using whole cells. The neutral antagonist20, equipped with a 5-TAMRA dye, displayed rapid association to the D2longR in binding studies using confocal microscopy demonstrating its suitability for fluorescence microscopy. Furthermore, in molecular brightness studies, the ligand’s binding affinity could be determined in a single-digit nanomolar range that was in good agreement with radioligand binding data. Therefore, the fluorescent compound can be used for quantitative characterization of native D2-like receptors in a broad variety of experimental setups..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 22. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nagl, Martin [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.09.25.559398 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI040982335 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI040982335 | ||
| 003 | DE-627 | ||
| 005 | 20231223090616.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231002s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.09.25.559398 |2 doi | |
| 035 | |a (DE-627)XBI040982335 | ||
| 035 | |a (biorXiv)10.1101/2023.09.25.559398 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nagl, Martin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fluorescent Tools for Imaging and Ligand Screening of Dopamine D<sub>2</sub>-Like Receptors |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The family of dopamine D2-like receptors represent an interesting target for a variety of neurological diseases, e.g. Parkinson’s disease (PD), addiction or schizophrenia. In this study we describe the synthesis of a new set of fluorescent ligands as tools for visualization of dopamine D2-like receptors. Pharmacological characterization in radioligand binding studies identified UR-MN212 (20) as a high-affinity ligand for D2-like receptors (pKi(D2longR) = 8.24, pKi(D3R) = 8.58, pKi(D4R) = 7.78) with decent selectivity towards D1-like receptors. Compound20is a neutral antagonist in a Go1activation assay at the D2longR, D3R and D4R, which is an important feature for studies using whole cells. The neutral antagonist20, equipped with a 5-TAMRA dye, displayed rapid association to the D2longR in binding studies using confocal microscopy demonstrating its suitability for fluorescence microscopy. Furthermore, in molecular brightness studies, the ligand’s binding affinity could be determined in a single-digit nanomolar range that was in good agreement with radioligand binding data. Therefore, the fluorescent compound can be used for quantitative characterization of native D2-like receptors in a broad variety of experimental setups. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Mönnich, Denise |0 (orcid)0000-0001-8872-2806 |4 aut | |
| 700 | 1 | |a Rosier, Niklas |0 (orcid)0000-0003-2835-7928 |4 aut | |
| 700 | 1 | |a Schihada, Hannes |0 (orcid)0000-0002-1889-1636 |4 aut | |
| 700 | 1 | |a Sirbu, Alexei |0 (orcid)0000-0003-0240-7763 |4 aut | |
| 700 | 1 | |a Konar, Nergis |4 aut | |
| 700 | 1 | |a Reyes-Resina, Irene |0 (orcid)0000-0003-2077-2537 |4 aut | |
| 700 | 1 | |a Navarro, Gemma |0 (orcid)0000-0003-4654-0873 |4 aut | |
| 700 | 1 | |a Franco, Rafael |0 (orcid)0000-0003-2549-4919 |4 aut | |
| 700 | 1 | |a Kolb, Peter |4 aut | |
| 700 | 1 | |a Annibale, Paolo |4 aut | |
| 700 | 1 | |a Pockes, Steffen |0 (orcid)0000-0002-2211-9868 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 22. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:22 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.09.25.559398 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 22 |c 12 | ||